Comprehensive information about experimentally validated enhancers
| Enhancer ID: | E_01582 |
| Species: | Homo sapiens |
| Position : | chr12:48395262-48395977 |
| Year: | 2014 |
| Title: | Up-regulation of type II collagen gene by 17汕-estradiol in articular chondrocytes involves Sp1/3, Sox-9, and estrogen receptor 汐. |
| Genome Build: | hg19 |
| Enhancer Type: | Enhancer |
| Condition: | Normal |
| PMID: | 25081415 |
| Tissue: | articular cartilage |
| Cell Source: | Primary articular chondrocytes |
| Cell Type: | chondrocyte |
| Cell Ontology ID: | CL:0000138 |
| Experiment Type: | Enhancer activity assay; TF binding assay; Functional perturbation assay |
| Low Throughput Method: | Luciferase Reporter Assay; ChIP; Re-ChIP; EMSA; siRNA knockdown; RT-qPCR |
| Target gene : | COL2A1 |
| TF name : | SOX9 |
| Regulatory State : | Active |
| GeneName | Pathway Name | Source | Gene Number |
|---|---|---|---|
| SOX9 | Deactivation of the beta-catenin transactivating complex | reactome | 42 |
| SOX9 | TGF_beta_Receptor | netpath | 220 |
| SOX9 | Hs_Neural_Crest_Differentiation_WP2064_79263 | wikipathways | 40 |
| SOX9 | Hs_Spinal_Cord_Injury_WP2431_87678 | wikipathways | 21 |